BOSTON--(BUSINESS WIRE)--Nov. 22, 2005--Point Therapeutics, Inc. (NASDAQ: POTP) announced today the pricing of 8,050,000 shares of its common stock at $3.00 per share pursuant to an effective shelf registration statement. The net proceeds of the public offering are expected to be approximately $22.2 million. Point has also granted the underwriters in the offering an option to purchase up to an additional 1,207,500 shares of its common stock to cover over-allotments, if any. All shares are being offered by the company. The offering is expected to close on November 28, 2005. Pacific Growth Equities, LLC is the sole bookrunner with CIBC World Markets Corp. acting as a co-lead manager in the offering.
